BLANDIZZI, CORRADO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 157
NA - Nord America 149
AS - Asia 130
OC - Oceania 2
AF - Africa 1
SA - Sud America 1
Totale 440
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 148
HK - Hong Kong 55
RU - Federazione Russa 54
PL - Polonia 44
CN - Cina 32
SG - Singapore 23
IE - Irlanda 21
IT - Italia 21
SE - Svezia 11
IN - India 10
VN - Vietnam 4
KR - Corea 3
AU - Australia 2
DE - Germania 2
ES - Italia 2
JO - Giordania 2
BR - Brasile 1
CA - Canada 1
FI - Finlandia 1
GB - Regno Unito 1
JP - Giappone 1
NG - Nigeria 1
Totale 440
Salva come PNG Salva come JPEG
Città #
Hong Kong 52
Warsaw 44
Moscow 27
Dublin 21
Fairfield 21
Chandler 18
Shanghai 18
West Jordan 14
Singapore 13
Ashburn 10
Cambridge 10
Wilmington 10
Woodbridge 9
Florence 6
Houston 6
Seattle 6
Altamura 5
Lawrence 5
Chennai 4
Dong Ket 4
Princeton 4
Rome 4
Bhubaneswar 3
Boston 3
Buffalo 3
Barcelona 2
New York 2
Sydney 2
Andover 1
Beijing 1
Boardman 1
Bremen 1
Castelliri 1
Chandigarh 1
Genova 1
Grosseto 1
Hangzhou 1
Jacksonville 1
Kagoya 1
Lagos 1
Livorno 1
London 1
Los Angeles 1
Mumbai 1
Norwalk 1
Nuremberg 1
Pisa 1
Portland 1
Rui'an 1
San Diego 1
Seongnam 1
São Paulo 1
Toronto 1
Totale 351
Salva come PNG Salva come JPEG
Nome #
Clinical differences among the elderly admitted to the emergency department for accidental or unexplained falls and syncope 111
Deepening the Mechanisms of Visceral Pain Persistence: An Evaluation of the Gut-Spinal Cord Relationship 76
Hepatitis C virus infection: opportunities for an earlier detection in primary care 53
Adverse drug reactions in oncoLogy: intEnsive monitoring program on drug toXicity of biotechnological medicatioNs anD taRget therapies in Oncologic patientS - the ALEXANDROS observational study 31
Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy 18
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 17
Time to biologic treatment and to total colectomy associated with diagnostic delay in ulcerative colitis: Analysis of an Italian regional administrative healthcare database 12
Adherence to mesalazine and identification of patients with ulcerative colitis in healthcare administrative databases of Tuscany (Italy) 12
Utilization patterns and healthcare accesses of JAKi used in rheumatoid arthritis patients in Tuscany: The LEONARDO study 12
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 11
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy 11
Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact 11
Switching from infliximab-originator to infliximab-biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy 10
Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases 10
Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy) 9
Direct health care costs among patients with rheumatoid arthritis before and after the initiation of treatment with JAKi in Tuscany: The LEONARDO study 9
Diagnostic delay, effectiveness and safety outcomes in a real-world cohort of patients with Crohn's disease: Data from administrative databases in Tuscany, Italy 9
THE ECONOMIC IMPACT OF THE INTRODUCTION OF INFLIXIMAB-BIOSIMILAR: AN EMPIRICAL ANALYSIS USING THE TUSCANY HEALTHCARE ADMINISTRATIVE DATABASES 8
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis 8
Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy 7
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 7
Trajectories of adherence to biologic disease-modifying anti-rheumatic drugs in tuscan administrative databases: The pathfinder study 7
The Anti-TNF Drugs and the Risk of Lymphoma, Skin Cancer and Melanoma: A Signal Detection Analysis 6
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases 5
Totale 470
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.754
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.754
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202023 0 1 0 1 2 3 4 4 4 2 1 1
2020/202179 2 6 4 16 4 10 4 10 5 10 2 6
2021/202221 1 0 0 2 1 1 0 2 1 4 3 6
2022/202382 7 12 4 9 8 12 10 11 7 1 1 0
2023/2024183 0 5 3 23 4 7 4 62 6 36 5 28
2024/202558 39 19 0 0 0 0 0 0 0 0 0 0
Totale 470